Article Details

VISEN Pharmaceuticals Closes $150 Million Series B Financing to Accelerate the Development ...

Retrieved on: 2021-01-09 03:00:00

Tags for this article:

Click the tags to see associated articles and topics

VISEN Pharmaceuticals Closes $150 Million Series B Financing to Accelerate the Development .... View article details on hiswai:

Excerpt

Since its founding in 1974, Sofinnova has been active in life science ... The OrbiMed team, composed of over 80 distinguished scientific, medical, ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo